Engineered DNA polymerase variants
US11060075B2 · kind B2 · utility
1Cited by
132References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 28, 2019 |
| Grant date | Jul 13, 2021 |
| Priority date | — |
| Expiry date | Oct 28, 2039 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/9126
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention provides engineered DNA polymerase polypeptides and compositions thereof, as well as polynucleotides encoding the engineered DNA polymerase polypeptides. The invention also provides methods for use of the compositions comprising the engineered DNA polymerase polypeptides for diagnostic and other purposes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.